While number of total CD19+ B cells was unchanged over time (Figure S5A), percentage of CD27+ CD38+ plasmablasts from total CD19+ B cells increased from approximately 0.75% at baseline to more than 15% on day 7 after infection (Figure 3D). The gene discussed is CD19; the disease is infection.